Mathematical Models and Computer Simulations are the New
Frontiers in COVID19 Drug Trials

Mathematical Models and Computer Simulations are the New Frontiers in COVID19 Drug Trials

Thu, 22 Jul 2021

Researchers are using computer models to simulate COVID-19 infections on a cellular level—the basic structural level of the human body. The models allow for virtual trials of drugs and vaccines, opening the possibility of pre-assessment for drug and vaccine efficacy against the virus. The research team at the University of Waterloo includes Anita Layton, a professor of applied mathematics, and Mehrshad Sadria, an applied mathematics doctoral student. The team uses in silico experiments to replicate how the human immune system deals with the COVID-19 virus. In silico refers to trials situated in the silicon of computer chips, as opposed to in vitro or in vivo experiments, situated in test tubes or directly in living organisms. “It’s not that in silico trials should replace clinical trials,” Layton says. “A model is a simplification, but it can help us whittle down the drugs for clinical trials. Clinical trials are expensive and can cost human lives. Using models helps narrow the drug candidates to the ones that are best for safety and efficacy.” The researchers, among the first to be [working on these models](https://www.eurekalert.org/pub_releases/2021-07/uow-mma071621.php), were able to capture the results of different treatments that were used on COVID-19 patients in clinical trials. They say that their results, published in the journal Viruses, are remarkably consistent with live data on COVID-19 infections and treatments. One example of a treatment used in the model was Remdesivir, a drug that was used in the World Health Organization’s global SOLIDARITY trials. The simulated model and the live trial both showed the drug to be biologically effective but clinically questionable, unless administered shortly after viral infection. The model might also work for current and future variants of concern. The researchers anticipate the virus will continue to undergo mutation, which could precipitate new waves of infection. “As we learn more about different variants of concern, we can change the model’s structure or parameters to simulate the interaction between the immune system and the variants,” Sadria says. “[Then we can] predict if we should apply the same treatments or even how the vaccines might work, as well.” Edited by Gary Cramer The post [Mathematical Models and Computer Simulations are the New Frontiers in COVID-19 Drug Trials](https://acrpnet.org/2021/07/22/mathematical-models-and-computer-simulations-are-the-new-frontiers-in-covid-19-drug-trials/) appeared first on [ACRP](https://acrpnet.org/).

Related Articles

New method for tracking RNA with fluorescence

New method for tracking RNA with fluorescence

Clinical Trial Manager Gets Candid About The Research
Industry, Becoming A Generalist Ep.550

Clinical Trial Manager Gets Candid About The Research Industry, Becoming A Generalist Ep.550

Fast-Tracking New Treatments into Clinical Trials for
Children with Cancer

Fast-Tracking New Treatments into Clinical Trials for Children with Cancer

Unpicking Salmonella's survival strategies

Unpicking Salmonella's survival strategies

The Niche Episode 068 – Eli Lilly + ProQR, Sanofi + Kadmon,
Lycia, BlueBird + 2seventy, Mammoth

The Niche Episode 068 – Eli Lilly + ProQR, Sanofi + Kadmon, Lycia, BlueBird + 2seventy, Mammoth

Full Interview With The Clinical Trials Guru on California,
Money and Clinical Research

Full Interview With The Clinical Trials Guru on California, Money and Clinical Research

Another Way Job Seekers Can Get Their Foot In The Door In
The Clinical Research Industry

Another Way Job Seekers Can Get Their Foot In The Door In The Clinical Research Industry

Jumpcode Genomics and TGen collaborate on genomic sequencing
of SARS-CoV-2

Jumpcode Genomics and TGen collaborate on genomic sequencing of SARS-CoV-2

Preventing Malaria: A Glimmer of Hope?

Preventing Malaria: A Glimmer of Hope?

Bacterial survival under starvation conditions

Bacterial survival under starvation conditions

MD Anderson and SNIPR BIOME join forces to advance new
CRISPR-based microbiome therapeutics

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

Shining (Invisible) Light On Viral Pathogens: Virucidal
Contamination Control Strategies Using UV-C Light

Shining (Invisible) Light On Viral Pathogens: Virucidal Contamination Control Strategies Using UV-C Light

Return of the mammoth? George Church-backed company launches
with $15 million for elephant-sized quest

Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest

Burnout Threatens to Undermine Clinical Trial Workforce
Productivity

Burnout Threatens to Undermine Clinical Trial Workforce Productivity

Researchers discover transposon-encoded RNA-guided nucleases
with potential for genome editing

Researchers discover transposon-encoded RNA-guided nucleases with potential for genome editing

First rat model recapitulates all disabling alterations
experienced by patients with Morquio A disease

First rat model recapitulates all disabling alterations experienced by patients with Morquio A disease

Phage therapy: The era of personalized medicine

Phage therapy: The era of personalized medicine

Why You Should Get Your Start At a Small Biotech Company
(Part 3)

Why You Should Get Your Start At a Small Biotech Company (Part 3)

New precision-guided sterile insect technique designed to
control disease-spreading mosquitoes

New precision-guided sterile insect technique designed to control disease-spreading mosquitoes

Collaborative Development Begins on Novel Digital Data Flow
Solution for Study Start-Up

Collaborative Development Begins on Novel Digital Data Flow Solution for Study Start-Up

Patients Deserve Remote Clinical Trial Options

Patients Deserve Remote Clinical Trial Options

‘All of Us’ Program Taps New Partners to Promote Trial
Diversity

‘All of Us’ Program Taps New Partners to Promote Trial Diversity

Many Unproven Cancer Drugs Continue to be Recommended for
Patients

Many Unproven Cancer Drugs Continue to be Recommended for Patients

What Data Can Clinical Research Sites Collect About
Themselves To Remain Relevant Next Decade?

What Data Can Clinical Research Sites Collect About Themselves To Remain Relevant Next Decade?

ICH Q12 meets FDA acceptance

ICH Q12 meets FDA acceptance

UC San Diego researchers receive $6 million NIH grant to
study insulin-producing cells

UC San Diego researchers receive $6 million NIH grant to study insulin-producing cells

New gene-delivering workhorse could make gene therapy safer,
more effective for muscle diseases

New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseases

We Answer Questions From A Clinical Research Coordinator Who
Probably Works For A Bad Site

We Answer Questions From A Clinical Research Coordinator Who Probably Works For A Bad Site